Rapid Implementation of Service Delivery Changes to Mitigate COVID-19 and Maintain Access to Methadone Among Persons with and at High-Risk for HIV in an Opioid Treatment Program
Open Access
- 1 September 2020
- journal article
- editorial
- Published by Springer Science and Business Media LLC in AIDS and Behavior
- Vol. 24 (9), 2469-2472
- https://doi.org/10.1007/s10461-020-02887-1
Abstract
No abstract availableThis publication has 28 references indexed in Scilit:
- HIV Treatment Outcomes Among HIV-Infected, Opioid-Dependent Patients Receiving Buprenorphine/Naloxone Treatment within HIV Clinical Care Settings: Results From a Multisite StudyJAIDS Journal of Acquired Immune Deficiency Syndromes, 2011
- Drug Treatment as HIV Prevention: A Research UpdateJAIDS Journal of Acquired Immune Deficiency Syndromes, 2010
- Methadone use among HIV-positive injection drug users in a Canadian settingJournal of Substance Abuse Treatment, 2010
- Methadone maintenance therapy promotes initiation of antiretroviral therapy among injection drug usersAddiction, 2010
- Retention in Opioid Substitution Treatment: A Major Predictor of Long‐Term Virological Success for HIV‐Infected Injection Drug Users Receiving Antiretroviral TreatmentClinical Infectious Diseases, 2009
- The effect of methadone maintenance on positive outcomes for opiate injection drug usersJournal of Substance Abuse Treatment, 2009
- Adherence to HIV treatment among IDUs and the role of opioid substitution treatment (OST)International Journal of Drug Policy, 2007
- Reduction in Injection–Related HIV Risk After 6 Months in a Low-Threshold Methadone Treatment ProgramAIDS Education and Prevention, 2007
- Methadone treatment as a determinant of HIV risk reduction among injecting drug users: A nested case-control studyAIDS Care, 1994